Bicycle Therapeutics (BCYC) Earnings Date & Reports

A.I. Advisor

published Earnings

BCYC is expected to report earnings to rise 5.30% to -81 cents per share on October 31

Bicycle Therapeutics BCYC Stock Earnings Reports

Q3'24

Est.

$-0.81

Q2'24

Beat

by $0.36

Q1'24

Beat

by $0.63

Q4'23

Beat

by $0.08

Q3'23

Missed

by $0.06

The last earnings report on August 06 showed earnings per share of -76 cents, beating the estimate of -112 cents. With 122.80K shares outstanding, the current market capitalization sits at 1.60B.

View a ticker or compare two or three

Compare

BCYC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BCYC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BCYC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a holding company, which engages in the development of biopharmaceuticals.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Granta Park, Great Abington

Phone

+44 1223261503

Employees

284

Web

https://www.bicycletherapeutics.com